Allison Rosen, MS (@arosen380) 's Twitter Profile
Allison Rosen, MS

@arosen380

#Cancer survivor, patient #advocate, Public #speaker, @AmericanCancer Director Project ECHO, @MDAndersonNews @SWOG volunteer. #crcsm #ayacsm Views my own

ID: 823634931175792641

linkhttps://coi.asco.org/share/JRA-W26E/Allison%20Rosen calendar_today23-01-2017 20:54:04

5,5K Tweet

3,3K Takipçi

3,3K Takip Edilen

Allison Rosen, MS (@arosen380) 's Twitter Profile Photo

Amazing talk by Andreana N. Holowatyj at ASCO summarizing the state of the knowledge of young onset colorectal cancer! These patients have unique needs & providers need to ensure they discuss options like fertility preservation & sexual health with ALL patients! #ASCO25 #CRCSM OncoAlert

Amazing talk by <a href="/drholowatyj/">Andreana N. Holowatyj</a> at <a href="/ASCO/">ASCO</a> summarizing the state of the knowledge of young onset colorectal cancer! These patients have unique needs &amp; providers need to ensure they discuss options like fertility preservation &amp; sexual health with ALL patients! #ASCO25 #CRCSM <a href="/OncoAlert/">OncoAlert</a>
Eleonora Teplinsky, MD (@drteplinsky) 's Twitter Profile Photo

Thank you ASCO for the opportunity to chair this education session focusing on technology in medical education: AI, gamification and digital and social media. Will be on demand later if you missed it! Great panel with Caroline Chung, MD and Traci Wolbrink. Huge thank you to Jasmin Hundal, M.D., DipABLM, M.S., M.P.H. and

Thank you <a href="/ASCO/">ASCO</a> for the opportunity to chair this education session focusing on technology in medical education: AI, gamification and digital and social media. Will be on demand later if you missed it! Great panel with <a href="/ca_chung/">Caroline Chung, MD</a> and <a href="/wolbrinkt/">Traci Wolbrink</a>. Huge thank you to <a href="/HundalJasmin/">Jasmin Hundal, M.D., DipABLM, M.S., M.P.H.</a> and
Vivek Subbiah, MD (@viveksubbiah) 's Twitter Profile Photo

🚨 Wow! #ASCO25 ASCO was absolutely massive! 10 NEJM papers published simultaneously 👉 all practice-changing studies ! 🔬✨🧵 See below for these studies 👇@oncoalert

Allison Rosen, MS (@arosen380) 's Twitter Profile Photo

As I wrap up an amazing ASCO mtg, I am reflecting on how lucky I am to attend! I was 1 of 700 patient advocates who dedicate their lives to represent the millions of patients diagnosed with cancer. I can’t wait to see what this next yr brings when we all work together! #ASCO25

Ramy Sedhom, MD, FASCO (@ramsedhom) 's Twitter Profile Photo

Today, I spoke Northwestern Medicine Grand Rounds on “The Price of Progress” - a reminder our excitement post-#ASCO25 should be tempered by reality: 🧾 33% of pts spend their life savings within 2 yrs of a cancer dx 🧠 50% experience financial distress 💼 75% leave the workforce

Smitha Krishnamurthi (@smitha42) 's Twitter Profile Photo

Great point and great The New York Times interactive article in which you can look up institutions and canceled grants. ➡️1,380 grants have been terminated this year compared to the usual of 20 per year. ➡️Call your Senators to ask them to vote against the proposed 40% cut to NIH budget

OncoAlert (@oncoalert) 's Twitter Profile Photo

DEAR COLLEAGUES🚨 You are warmly invited to watch the Top Trials of the Year, presented by some of the world’s leading experts. JUST CLICK AND WATCH ⭐ GU Oncology buff.ly/3hkYYG6 ⭐ #BreastCancer buff.ly/EH7RPPc ⭐ #LungCancer 🫁 @Mascc #SupportiveCare

Udhayvir Grewal (@ugrewalmd) 's Twitter Profile Photo

🚨 NEW in ESMO GI Oncology: Massive multi-cohort study (>560,000 patients) investigating the relatively aggressive disease biology of yo-CRC: 🧬 Disproportionate prevalence of CMS4 mesenchymal subtype, linked to poor prognosis, recurrence, and stromal infiltration-- may explain

🚨 NEW in ESMO GI Oncology:
Massive multi-cohort study (&gt;560,000 patients) investigating the relatively aggressive disease biology of yo-CRC:
🧬 Disproportionate prevalence of CMS4 mesenchymal subtype, linked to poor prognosis, recurrence, and stromal infiltration-- may explain
Dr. Kelly Shanahan (@stage4kelly) 's Twitter Profile Photo

Pre-cancer QoL was v good to excellent, but that dropped significant after being diagnosed with cancer. Fatigue was the #1 side effect negatively impacting QoL. Stacey Tinianov (she/her) MPH, BCPA #mascc25

Pre-cancer QoL was v good to excellent, but that dropped significant after being diagnosed with cancer. Fatigue was the #1 side effect negatively impacting QoL. <a href="/coffeemommy/">Stacey Tinianov (she/her) MPH, BCPA</a> #mascc25
Fight Colorectal Cancer (@fightcrc) 's Twitter Profile Photo

🚨 BREAKING: The U.S. Supreme Court has upheld the constitutionality of the Affordable Care Act in Braidwood v. Kennedy, preserving no-cost access to preventive services—including colorectal cancer screening. Colorectal cancer (CRC) is the second-leading cause of cancer-related

🚨 BREAKING: The U.S. Supreme Court has upheld the constitutionality of the Affordable Care Act in Braidwood v. Kennedy, preserving no-cost access to preventive services—including colorectal cancer screening.

Colorectal cancer (CRC) is the second-leading cause of cancer-related